Alper Uysal

Dr. Alper Uysal


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Batı Karadeniz Tıp Dergisi
Verified
Journal Article
Closed access
PDF file
AUAlper Uysal
Alper Uysal
MUMerve Erdem Uysal
Merve Erdem Uysal
Aim: Avascular necrosis of the femoral head is a condition characterized by limited range of motion, pain, and gait disturbance resulting from insufficient blood flow. We aim to evaluate the relationship between COVID-19 and avascular necrosis. Case: Herein, we present a 63-year-old male patient who developed avascular necrosis of the bilateral femoral head after COVID-19. Conclusion: COVID-19 infection alone and corticosteroids given to treat it can increase the incidence of avascular necrosis of the femoral head. MRI of the hip is highly specific in detecting early stagea vascular necrosis of the femoral head and can reduce patient’s disability and need for surgery.

28 April 2023 in Batı Karadeniz Tıp Dergisi
Verified
Journal Article
Open access
PDF file
AUAlper Uysal
Alper Uysal
MGMurat Güntel
Murat Güntel
Aim: Neck pain is one of the most prevalent medical complaints. Chronic pain conditions can lead to depression, anxiety and sleep problems in individuals. Thus, both the pain itself and the psychiatric problems it causes impair the quality of life of the patient. Depression and anxiety can also cause changes in the perception of pain. In this study, we aimed to investigate the effects of cervical disc herniation (CDH), which causes chronic neck pain, on the level of neck disability, sleep quality, anxiety and depression. Material and Methods: Patients’ pain intensity, neck disability indexes, depression and anxiety status, and sleep quality were evaluated using a visual analog scale (VAS), the neck disability index (NDI), Beck Depression Inventory (BDI), beck anxiety inventory (BAI) and the Pittsburgh Sleep Quality Index (PSQI), respectively. Results: We found a statistically significant relationship between CDH and anxiety, depression and sleep quality. In addition, we found higher levels of pain, anxiety and depression in the group with poor sleep quality. Conclusion: For optimal treatment approaches of patients with chronic neck pain, accompanying sleep disorder, depression and anxiety should also be evaluated.

1 September 2023
Verified
Journal Article
Open access
AUAlper Uysal
Alper Uysal
MGMurat Guntel
Murat Guntel
ODOzcan Demetgul
Ozcan Demetgul
UCUlac Cicek
Ulac Cicek
Objectives: Both Parkinson's disease (PD) and osteoarthritis (OA) are characterized by chronic inflammation and tissue degeneration. The aim of this study is to investigate the relationship between PD and distal femoral cartilage thickness (DFCT). Our study is the first in the literature to measure DFCT in PD. Methods: 68 patients with PD and 30 healthy individuals participated. The patient group was divided into three subgroups, according to the Hoehn Yahr stages (HYS): mild, moderate and severe. Patient subgroups and the control group were compared with each other in terms of neutrophillymphocyte ratio (NLR), C-reactive protein (CRP), and DFCT. Results: The NLR and CRP levels of the PD patients were higher than the values of the healthy people. The DFCT values of the mild PD subgroup were significantly higher than those of the control group, except for one value. The DFCT values of the moderate PD subgroup and the healthy group were similar. The DFCT values of the severe PD subgroup were lower than the values of the healthy group. Conclusions: Our study showed the presence of ultrasonographic evidence consistent with early signs of cartilage destruction in early-stage PD disease. As the PD stage progressed, the cartilage thickness decreased accordingly.

1 January 2022 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
MGMurat Güntel
Murat Güntel
AUAlper Uysal
Alper Uysal
IMIsmet Melek
Ismet Melek
Purpose: We aimed to investigate the factors affecting the etiopathogenesis by comparing the restless legs syndrome patients with the healthy control group in terms of some laboratory parameters. Materials and Methods: Patients who were diagnosed with restless legs syndrome were included in the study. A control group that was similar in terms of age and gender was formed. Both groups were compared in terms of iron, ferritin, iron-binding capacity, folate, vitamin B12, vitamin D, calcium, magnesium, ALT, AST, hemogram, creatinine, fasting blood sugar, and thyroid hormone levels. Results: 37 patients with restless legs syndrome and 41 controls were included in the study. In the restless legs syndrome group hemoglobin, ferritin, iron, fasting blood sugar, vitamin D, and fT4 values were 12.7 (10.3-16.0) g/dL, 37.3 (3.7-89.4) mg/L, 62 (21-195) mu g/dL, 96 (65-250) mg/L, 11.26 (4.20-41.57) ug/L and 1.24 (0.73-2.14) mu g/dL respectively, they were 14.8 (12.3-16.1) g/dL, 56 (9-189) mg/L, 90 (30-245) mu g/dL, 91 (70-107) mg/L, 17.31 (5.73-32.90) mu g/L and 1.08 (0.63-2.04) mu g/dL respectively in the control group.There were statistically significant differences between the groups in terms of hemoglobin, ferritin, iron, fasting blood sugar, vitamin D, and fT4 levels. Conclusion: Hemoglobin and iron parameters, vitamin D levels, fasting blood sugar and T4 levels should be evaluated in patients with restless legs syndrome and should be replaced if necessary. Correction of deficiencies may be beneficial for patients' clinics.

25 June 2025 in Rheumatology Quarterly
Verified
Journal Article
Open access
AUAlper Uysal
Alper Uysal
ADAli Nail Demir
Ali Nail Demir
UDUğur Güngör Demir
Uğur Güngör Demir
Aim:The objective of this study was to evaluate the impact of various treatment options on bone mineral density (BMD) in postmenopausal women with rheumatoid arthritis (RA). Material and Methods:A retrospective analysis was conducted on the data of 163 postmenopausal women, including 121 RA patients meeting the 2010 American College of Rheumatology/European League Against Rheumatism criteria and 42 healthy controls. RA patients were categorized into four groups based on their treatment regimens: Group 1, receiving conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) alone; Group 2, receiving csDMARDs in combination with glucocorticosteroids (GCs); Group 3, receiving csDMARDs with GCs and biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs); and Group 4, receiving b/tsDMARDs combined with methotrexate. Data collected included demographic information, BMD T-scores at lumbar spine (L1-L4), femoral neck, total hip, and serum calcium, and vitamin D levels. Results:RA patients had significantly lower BMD T-scores at L1-L4, femoral neck, and total hip compared to controls (p=0.041, p=0.026, and p=0.003, respectively). Among treatment groups, patients receiving csDMARDs with GCs exhibited greater bone loss, particularly in femoral neck scores, compared to other regimens (all p≤0.005). Conversely, b/tsDMARDs showed a protective effect on BMD, mitigating bone loss despite the use of low-dose GCs. Conclusion:This study demonstrates that RA treatments significantly influence BMD in postmenopausal women. b/tsDMARDs appear to mitigate the adverse effects of GCs on bone health, while prolonged GC use is associated with greater bone loss, especially in the csDMARDs group.

1 June 2023
Verified
Journal Article
Closed access
AUAlper Uysal
Alper Uysal
MGMurat Guntel
Murat Guntel
HDHava Oezlem Dede
Hava Oezlem Dede